Table 1. Final Population Pharmacokinetic Parameter Estimates of Metoprolol in Geriatric Patients with Comorbidities.
Parameter | Estimate | S.E. (lin) | R.S.E. (%) | p-value |
---|---|---|---|---|
Tlag (hr): Lag Time | 0.469 | 0.017 | 4 | |
Ka (hr-1): Absorption Rate Constant | 0.235 | 0.02 | 8 | |
V (L): Volume of Distribution | 38 | 36 | 95 | |
CLFemales (L/hr): Apparent Female Clearance | 59.1 | 6.9 | 12 | |
CLMales (L/hr): Apparent Male Clearance | 105 | 10 | 10 | |
beta CLMale (%): increase in clearance rate in males | 0.572 | 0.14 | 24 | 2.70E-05 |
Interindividual Variability | CV % | |||
ωTlag, variance for Tlag | 0.0304 | 0.034 | 113 | 17% |
ωKa, variance for Ka | 0.0518 | 0.13 | 254 | 23% |
ωV, variance for V | 2.43 | 0.67 | 27 | 155% |
ωCL, variance for CL | 0.143 | 0.055 | 39 | 38% |
σ (ng/mL): Residual (intra-individual) concentration | 12.2 | 1.2 | 10 |
CV (%), interindividual deviation of each parameter; RSE (%), percentage of relative standard error (100%×SE/EST); σ, variance of intraindividual deviation of fitted metoprolol plasma concentration.